Sign In | Join Free | My phrmg.org
phrmg.org
Hubei Jusheng Technology Co., Ltd.
Honesty is fundamental,Quality is life,lnnovation is power, and Service is soul!
Home > Anti Inflammatory Medicine >

Pharmaceutical Anti Inflammatory Medicine Raw Materials Anidulafungin 166663-25-8

Hubei Jusheng Technology Co., Ltd.
Trust Seal
Verified Supplier
Credit Check
Supplier Assessment
Hubei Jusheng Technology Co., Ltd.
City: Wuhan
Province/State: Hubei
Country/Region: China
Tel: 0086-27-59599243
Contact Person:
Miss Linda

Pharmaceutical Anti Inflammatory Medicine Raw Materials Anidulafungin 166663-25-8

Brand Name : Jusheng Brand
Model Number : 166663-25-8
Certification : ISO, 9001, USP
Place of Origin : China
MOQ : 10grams
Price : Discount is possible if your order is big enough
Payment Terms : T/T in advance, Money Gram, Western Union, Bank Transfer.
Supply Ability : 1000kg/month
Delivery Time : within 2 working days
Packaging Details : 10g, 20g, 50g , 100g, 500g. 1kg, 10kg
CAS : 166663-25-8
Alias : Anidulafungin;Echinocandin B
Apparence : Almost White Crystalline Powder
Purity : 99.5%
Usage : for HIV treatment
Stock : Enough Stock
Contact Now

Pharmaceutical Raw Materials Anidulafungin 166663-25-8 for HIV treatment


Quick detail


Product Name: Anidulafungin
Synonyms: Anidulafungin;Echinocandin B, 1-(4R,5R)-4,5-dihydroxy-N2-4-(pentyloxy)1,1:4,1-terphenyl-4-ylcarbonyl-L-ornithine-;Anidulafungin(LY303366);Ecalta;Eraxis;LY 303366;LY 303366, Eraxis;1-[(4R,5R)-4,5-dihydroxy-N2-[[4''-(pentyloxy)[1,1'',1''-terphenyl]-4-yl]carbonyl]-L-ornithine]-echinocandin B
CAS: 166663-25-8
MF: C58H73N7O17
MW: 1140.25
EINECS:
Product Categories: Antifungals;API;Inhibitors


Anidulafungin​ Introduction


Anidulafungin (brand names: Eraxis (in U.S. and Russia), Ecalta (in Europe)) is a semisynthetic echinocandin used as an antifungal drug. Anidulafungin was originally manufactured and submitted for FDA approval by Vicuron Pharmaceuticals. Pfizer acquired the drug upon its acquisition of Vicuron in the fall of 2005. Pfizer gained approval by the Food and Drug Administration (FDA) on February 21, 2006; it was previously known as LY303366. Preliminary evidence indicates it has a similar safety profile to caspofungin. Anidulafungin has proven efficacy against esophageal candidiasis, but its main use will probably be in invasive Candida infection; it may also have application in treating invasive Aspergillus infection. It is a member of the class of antifungal drugs known as the echinocandins; its mechanism of action is by inhibition of (1→3)-β-D-glucan synthase, an enzyme important to the synthesis of the fungal cell wall.


Medical Application API:


UsageAnidulafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class that was reported in 1995 and commercially developed by Eli Lilly. Anidulafungin inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the cell wall of susceptible fungi and is extensively referenced in the literature with over 400 citations.
Usagenucleoside reverse transcriptase inhibitor (NRTI) for HIV treatment in adults
DefinitionChEBI: A semisynthetic echinocandin anti-fungal drug. It is active against Aspergillus and Candida species and is used for the treatment of invasive candidiasis.



Product Tags:

anti histaminic drugs

      

anti allergy medicine

      
China Customized Inflatable Bumper Ball Game Bubble Adult Grass CE supplier

Pharmaceutical Anti Inflammatory Medicine Raw Materials Anidulafungin 166663-25-8 Images

Inquiry Cart 0
Send your message to this supplier
 
From:
Enter your email please.
To: Hubei Jusheng Technology Co., Ltd.
Subject:
Message:
Characters Remaining: (0/3000)